Case Study: Illumina explains drug-resistant TB with Explanimate!

A Explanimate Case Study

Preview of the Illumina Case Study

Illumina explains drug-resistant TB in a 3-minute animation with Explanimate

Illumina, a global leader in genomics, faced the challenge of explaining the complex role of Next Generation Sequencing (NGS) in combating drug-resistant tuberculosis to a diverse, specialist audience. They partnered with the animation studio Explanimate to transform this intricate scientific subject into a clear and compelling narrative that was both credible and accessible.

Explanimate developed an explainer video that used warm, relatable visuals and a carefully crafted script to illustrate how NGS provides faster, more comprehensive data for treatment and surveillance. The solution balanced scientific accuracy with a human-centered message, resulting in a powerful educational asset for World TB Day. The final animation gave Illumina a clear and shareable resource to communicate the value of its health technology, turning a complex topic into an understandable and memorable campaign.


View this case study…

Explanimate

62 Case Studies